English | Español
Patient Daily | Mar 16, 2026

Senator Ron Johnson launches investigation into FDA rare disease rejections
Patient Daily | Mar 16, 2026

Global physical activity levels remain low despite widespread policy adoption
Patient Daily | Mar 16, 2026

Dyne Therapeutics reports sustained benefits for Duchenne therapy in long-term study data
Patient Daily | Mar 16, 2026

Stylus Medicine pursues in vivo CAR T cell therapy amid industry shifts
Patient Daily | Mar 16, 2026

Breakout Ventures raises $114 million to support early-stage AI biotech startups
Patient Daily | Mar 16, 2026

Cell and gene therapy manufacturing market projected to reach $146 billion by 2032
Patient Daily | Mar 16, 2026

Nonprofit seeks to modernize drug manufacturing by removing capital barriers
Patient Daily | Mar 16, 2026

FDA outlines scope for meetings to reduce drug approval rejections over manufacturing

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug